Cargando…
Sinonasal mucosal melanoma: treatment strategies and survival rates for a rare disease entity: A single center experience and review of literature
BACKGROUND: Sinonasal mucosal melanoma (SNMM) is a rare disease entity comprising 0.4–1.3% of all melanomas. Surgery with free margins has been the primary treatment over decades. Neither the addition of radiotherapy nor chemotherapy could significantly improve outcome rates of this devastating mali...
Autores principales: | Andrianakis, Alexandros, Kiss, Peter, Pomberger, Markus, Wolf, Axel, Thurnher, Dietmar, Tomazic, Peter Valentin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Vienna
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8599389/ https://www.ncbi.nlm.nih.gov/pubmed/33844113 http://dx.doi.org/10.1007/s00508-021-01847-6 |
Ejemplares similares
-
Optic nerve injury in preoperative imaging is associated with visual improvement outcome in endoscopic optic nerve decompression
por: Leitner, Isabella, et al.
Publicado: (2021) -
Observing the brain pulsating
por: Andrianakis, Alexandros, et al.
Publicado: (2021) -
Evolution in Sinonasal Mucosal Melanoma Management
por: Richa, Tony, et al.
Publicado: (2022) -
PTEN Methylation Dependent Sinonasal Mucosal Melanoma
por: Lee, Sang Hee, et al.
Publicado: (2016) -
Contemporary Multidisciplinary Management of Sinonasal Mucosal Melanoma
por: Na’ara, Shorook, et al.
Publicado: (2020)